CVE-2018-5237
Symantec Endpoint Protection prior to 14 RU1 MP1 or 12.1 RU6 MP10 could be susceptible to a privilege escalation vulnerability, which is a type of issue that allows a user to gain elevated access to resources that are normally protected at lower access…
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (1.89%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
Symantec Endpoint Protection prior to 14 RU1 MP1 or 12.1 RU6 MP10 could be susceptible to a privilege escalation vulnerability, which is a type of issue that allows a user to gain elevated access to resources that are normally protected at lower access levels.
- CVSS 3.0
- 8.8 HIGHCVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 1.89% probability · 79th percentile
- Public exploits
- None in Exploit-DB
- CISA KEV
- Not listed
- Affected
- symantec/endpoint protection
- Source
- secure@symantec.com
EPSS 1.9% since 27 October 2026; no change recorded yet. Points are recorded when the score first appears and whenever it moves by a percentage point or more.
References
- http://www.securityfocus.com/bid/104199Third Party Advisory, VDB Entry
- http://www.securitytracker.com/id/1041180Third Party Advisory, VDB Entry
- https://support.symantec.com/en_US/article.SYMSA1454.htmlVendor Advisory
- http://www.securityfocus.com/bid/104199Third Party Advisory, VDB Entry
- http://www.securitytracker.com/id/1041180Third Party Advisory, VDB Entry
- https://support.symantec.com/en_US/article.SYMSA1454.htmlVendor Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA, exploits from Exploit-DB. Refreshed daily. Download this record as JSON.